Skip to main content

NCT00231530 - A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetic Patients on a Controlled Diet

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetic Patients on a Controlled Diet


Primary Citation

Not Yet Available


Data Specification

Not Available


Annotated CRF

Available upon data request approval

Product Info

Generic Name
Topiramate
Product Name
TOPAMAX®
Therapeutic Area
Nutritional and Metabolic Diseases
Enrollment
541
% Female
N/A
% White
N/A
Product Class
Anticonvulsants
Sponsor Protocol Number
TOPMAT-OBDM-003
Data Partner
Johnson & Johnson
Condition Studied
Diabetes Mellitus, Type 2, Obesity
Mean/Median Age (Years)
N/A

Supporting Documentation

Clinical Study Report
Collected Datasets
Annotated Case Report Form
Protocol with Amendments
Statistical Analysis Plan

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.